• Company
• Rolvedon's cumulative US sales surpasses ₩100B
• by Son, Hyung-Min May 21, 2024 05:55am

• Company
• Dong-A, Ildong join hands…R&D synergy and resources
• by Chon, Seung-Hyun May 21, 2024 05:55am

• Company
• Global RSV vaccines emerge…K-pharma enters clinical trials
• by Son, Hyung-Min May 20, 2024 05:42am

• Company
• ‘Much work remains to be done for new drug access in Korea'
• by Eo, Yun-Ho May 20, 2024 05:42am

• Policy
• NHIS completes pricing negotiations for Vemlidy, Brukinsa
• by Lee, Tak-Sun May 20, 2024 05:41am

• Company
• Welireg can be prescribed in general hospitals in Korea
• by Eo, Yun-Ho May 20, 2024 05:41am

• Policy
• Erwinase price increases… Imfinzi renews RSA
• by Lee, Tak-Sun May 20, 2024 05:41am

• Company
• 'Imfinzi' shown to be effective for liver cancer
• by Son, Hyung-Min May 17, 2024 05:47am

• Company
• Ferring Korea appoints Min-Jung Kim as new GM
• by Son, Hyung-Min May 17, 2024 05:47am

• Policy
• Daewoong develops 'Olumiant' generic…starts clinical trials
• by Lee, Hye-Kyung May 17, 2024 05:47am